Laurens A van Meeteren

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. pmc Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting
    Laurens A van Meeteren
    Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands
    J Biol Chem 287:18551-61. 2012
  2. ncbi request reprint TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy
    Laurens A van Meeteren
    Department of Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University Medical Center, Postzone S 1 P, PO Box 9600, 2300 RC Leiden, The Netherlands
    Curr Pharm Biotechnol 12:2108-20. 2011
  3. pmc Regulation of endothelial cell plasticity by TGF-β
    Laurens A van Meeteren
    Department of Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands
    Cell Tissue Res 347:177-86. 2012

Collaborators

Detail Information

Publications3

  1. pmc Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting
    Laurens A van Meeteren
    Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands
    J Biol Chem 287:18551-61. 2012
    ....
  2. ncbi request reprint TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy
    Laurens A van Meeteren
    Department of Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University Medical Center, Postzone S 1 P, PO Box 9600, 2300 RC Leiden, The Netherlands
    Curr Pharm Biotechnol 12:2108-20. 2011
    ....
  3. pmc Regulation of endothelial cell plasticity by TGF-β
    Laurens A van Meeteren
    Department of Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands
    Cell Tissue Res 347:177-86. 2012
    ..By selective targeting of TGF-β receptor signaling pathological EndMT may be inhibited for the therapeutic benefit of patients with cancer and fibrosis...